A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Identity & Access Management Architect

Security Engineering & ArchitectureConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$176.8k - $239.2k

About the Job

Requirements

  • A bachelor's degree in computer science, cybersecurity, engineering, or a related field, or equivalent experience.
  • At least 8 years of progressive experience in IAM, identity engineering, Directory Services, or related technology disciplines, including at least 5 years in architecture, engineering, or technical delivery roles designing and implementing complex identity solutions.
  • Experience delivering enterprise IAM solutions across IGA, PAM, access management, Active Directory, Entra ID, and hybrid or cloud identity.
  • Hands-on expertise in Active Directory and Entra ID, including directory architecture, synchronization, authentication, Conditional Access, privileged roles, security hardening, and troubleshooting.
  • Experience with SailPoint and BeyondTrust or CyberArk, and with SAML, OAuth 2.0, OIDC, SCIM, Kerberos, LDAP/LDAPS, REST APIs, and certificates.
  • Ability to script, automate, and review technical solutions using PowerShell, Microsoft Graph, REST APIs, and at least one of Python, JavaScript, or infrastructure-as-code tools.
  • Ability to translate architecture into working solutions, lead technical reviews, guide engineers, and communicate decisions to business and technology leaders.
  • Familiarity with cybersecurity frameworks and standards such as NIST CSF, NIST 800-53, and Zero Trust Architecture concepts.
  • Ability to influence senior stakeholders and drive adoption of modernized IAM concepts, processes, and technology decisions across complex, regulated environments.
  • Ability to communicate complex technical concepts as clear business impact.

Responsibilities

  • Define and own the enterprise IAM target architecture, technical standards, integration patterns, and roadmap across IGA, PAM, access management, directory services, cloud, and non-human identity.
  • Lead identity solution design and engineering execution from architecture review and proof of concept through implementation, testing, operational handoff, and ongoing improvement.
  • Own the technical direction of Active Directory, Entra ID, and hybrid identity, including tenant and directory architecture, synchronization, authentication, groups, privileged administration, and service resilience.
  • Drive directory modernization and security, including legacy authentication reduction, Tier 0 protection, hardening, recovery, and complex migration or incident support.
  • Architect, design, implement, and roll out identity lifecycle and governance capabilities, including joiner, mover, and leaver processes; automated provisioning; birthright access; role models; access reviews; and application onboarding through SailPoint and related integrations.
  • Define PAM architecture for privileged account discovery, credential vaulting and rotation, session controls, just-in-time access, emergency access, and integration with directory and governance platforms.
  • Establish access management standards for SSO, MFA, phishing-resistant and passwordless authentication, federation, and Conditional Access using appropriate modern protocols.
  • Define secure identity patterns for cloud workloads, service accounts, service principals, secrets, certificates, APIs, and AI agents, including ownership, least privilege, and lifecycle controls.
  • Partner with Cybersecurity, Infrastructure, Cloud, Applications, Data and AI, and Enterprise Architecture to address identity risk, strengthen detection and response, and embed Zero Trust principles.
  • Drive automation and reusable engineering practices, mentor IAM and directory engineers, and serve as a technical escalation point for complex identity issues.

Desired Qualifications

  • Experience in a regulated environment.
  • Certifications such as CISSP, Microsoft identity, SailPoint, BeyondTrust, or CyberArk.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs